These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 18334493)

  • 21. Citral derived amides as potent bacterial NorA efflux pump inhibitors.
    Thota N; Koul S; Reddy MV; Sangwan PL; Khan IA; Kumar A; Raja AF; Andotra SS; Qazi GN
    Bioorg Med Chem; 2008 Jul; 16(13):6535-43. PubMed ID: 18524600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase.
    Chan BC; Ip M; Lau CB; Lui SL; Jolivalt C; Ganem-Elbaz C; Litaudon M; Reiner NE; Gong H; See RH; Fung KP; Leung PC
    J Ethnopharmacol; 2011 Sep; 137(1):767-73. PubMed ID: 21782012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide.
    Couto I; Costa SS; Viveiros M; Martins M; Amaral L
    J Antimicrob Chemother; 2008 Sep; 62(3):504-13. PubMed ID: 18511413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
    Mahey N; Tambat R; Chandal N; Verma DK; Thakur KG; Nandanwar H
    Microbiol Spectr; 2021 Dec; 9(3):e0095121. PubMed ID: 34908453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indirubin potentiates ciprofloxacin activity in the NorA efflux pump of Staphylococcus aureus.
    Ponnusamy K; Ramasamy M; Savarimuthu I; Paulraj MG
    Scand J Infect Dis; 2010 Jul; 42(6-7):500-5. PubMed ID: 20380543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, biological evaluation and computational studies of acrylohydrazide derivatives as potential Staphylococcus aureus NorA efflux pump inhibitors.
    Kumar G; Goutami Godavari A; Tambat R; Kumar S; Nandanwar H; Elizabeth Sobhia M; Jachak SM
    Bioorg Chem; 2020 Nov; 104():104225. PubMed ID: 32992278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues.
    Felicetti T; Cannalire R; Burali MS; Massari S; Manfroni G; Barreca ML; Tabarrini O; Schindler BD; Sabatini S; Kaatz GW; Cecchetti V
    ChemMedChem; 2017 Aug; 12(16):1293-1302. PubMed ID: 28598572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of the antibacterial activity and efflux pump inhibitory effect of co-loaded piperine and gentamicin nanoliposomes in methicillin-resistant Staphylococcus aureus.
    Khameneh B; Iranshahy M; Ghandadi M; Ghoochi Atashbeyk D; Fazly Bazzaz BS; Iranshahi M
    Drug Dev Ind Pharm; 2015 Jun; 41(6):989-94. PubMed ID: 24842547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyrazolo[4,3-c][1,2]benzothiazines 5,5-dioxide: a promising new class of Staphylococcus aureus NorA efflux pump inhibitors.
    Sabatini S; Gosetto F; Serritella S; Manfroni G; Tabarrini O; Iraci N; Brincat JP; Carosati E; Villarini M; Kaatz GW; Cecchetti V
    J Med Chem; 2012 Apr; 55(7):3568-72. PubMed ID: 22432682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in silico inhibitory effects of synthetic and natural eugenol derivatives against the NorA efflux pump in Staphylococcus aureus.
    Muniz DF; Dos Santos Barbosa CR; de Menezes IRA; de Sousa EO; Pereira RLS; Júnior JTC; Pereira PS; de Matos YMLS; da Costa RHS; de Morais Oliveira-Tintino CD; Coutinho HDM; Filho JMB; Ribeiro de Sousa G; Filho JR; Siqueira-Junior JP; Tintino SR
    Food Chem; 2021 Feb; 337():127776. PubMed ID: 32777574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unlocking bacterial defense: Exploring the potent inhibition of NorA efflux pump by coumarin derivatives in Staphylococcus aureus.
    Martin ALAR; Pereira RLS; Rocha JE; Farias PAM; Freitas TS; Caldas FRL; Figueredo FG; Sampaio NFL; Oliveira-Tintino CDM; Tintino SR; da Hora GCA; Lima MCP; de Menezes IRA; Carvalho DT; Coutinho HDM; Fonteles MMF
    Microb Pathog; 2024 May; 190():106608. PubMed ID: 38503396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aminoguanidine hydrazones (AGH's) as modulators of norfloxacin resistance in Staphylococcus aureus that overexpress NorA efflux pump.
    Dantas N; de Aquino TM; de Araújo-Júnior JX; da Silva-Júnior E; Gomes EA; Gomes AAS; Siqueira-Júnior JP; Mendonça Junior FJB
    Chem Biol Interact; 2018 Jan; 280():8-14. PubMed ID: 29208359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the NorA efflux pump of S. aureus by (Z)-5-(4-Fluorobenzylidene)-Imidazolidines.
    Faillace MS; Alves Borges Leal AL; Araújo de Oliveira Alcântara F; Ferreira JHL; de Siqueira-Júnior JP; Sampaio Nogueira CE; Barreto HM; Peláez WJ
    Bioorg Med Chem Lett; 2021 Jan; 31():127670. PubMed ID: 33161124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus.
    Vidaillac C; Guillon J; Arpin C; Forfar-Bares I; Ba BB; Grellet J; Moreau S; Caignard DH; Jarry C; Quentin C
    Antimicrob Agents Chemother; 2007 Mar; 51(3):831-8. PubMed ID: 17101679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus.
    Aeschlimann JR; Dresser LD; Kaatz GW; Rybak MJ
    Antimicrob Agents Chemother; 1999 Feb; 43(2):335-40. PubMed ID: 9925528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and evaluation of new arylbenzo[b]thiophene and diarylthiophene derivatives as inhibitors of the NorA multidrug transporter of Staphylococcus aureus.
    Fournier Dit Chabert J; Marquez B; Neville L; Joucla L; Broussous S; Bouhours P; David E; Pellet-Rostaing S; Marquet B; Moreau N; Lemaire M
    Bioorg Med Chem; 2007 Jul; 15(13):4482-97. PubMed ID: 17498961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ferulic acid derivative inhibits NorA efflux and in combination with ciprofloxacin curtails growth of MRSA in vitro and in vivo.
    Sundaramoorthy NS; Mitra K; Ganesh JS; Makala H; Lotha R; Bhanuvalli SR; Ulaganathan V; Tiru V; Sivasubramanian A; Nagarajan S
    Microb Pathog; 2018 Nov; 124():54-62. PubMed ID: 30118803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-antibiotic agent ginsenoside 20(S)-Rh2 enhanced the antibacterial effects of ciprofloxacin in vitro and in vivo as a potential NorA inhibitor.
    Zhang J; Sun Y; Wang Y; Lu M; He J; Liu J; Chen Q; Zhang X; Zhou F; Wang G; Sun X
    Eur J Pharmacol; 2014 Oct; 740():277-84. PubMed ID: 25054686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural Modifications of the Quinolin-4-yloxy Core to Obtain New
    Cannalire R; Mangiaterra G; Felicetti T; Astolfi A; Cedraro N; Massari S; Manfroni G; Tabarrini O; Vaiasicca S; Barreca ML; Cecchetti V; Biavasco F; Sabatini S
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3-Aryl-4-methyl-2-quinolones targeting multiresistant Staphylococcus aureus bacteria.
    Doléans-Jordheim A; Veron JB; Fendrich O; Bergeron E; Montagut-Romans A; Wong YS; Furdui B; Freney J; Dumontet C; Boumendjel A
    ChemMedChem; 2013 Apr; 8(4):652-7. PubMed ID: 23436688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.